Rhabdomyolysis After Intravenous Iron Sucrose Infusion During Pregnancy

Iron infusions have become increasingly common in the treatment of iron-deficiency anemia during pregnancy. Although iron infusions are generally well tolerated, adverse reactions have been reported. A pregnant patient was diagnosed with rhabdomyolysis after receiving a second dose of intravenous (I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obstetrics and gynecology (New York. 1953) 2023-06, Vol.141 (6), p.1049-1051
Hauptverfasser: Ge, Christina, Reyes, Jessica, Queenan, Ruth Anne, Gherman, Robert B.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1051
container_issue 6
container_start_page 1049
container_title Obstetrics and gynecology (New York. 1953)
container_volume 141
creator Ge, Christina
Reyes, Jessica
Queenan, Ruth Anne
Gherman, Robert B.
description Iron infusions have become increasingly common in the treatment of iron-deficiency anemia during pregnancy. Although iron infusions are generally well tolerated, adverse reactions have been reported. A pregnant patient was diagnosed with rhabdomyolysis after receiving a second dose of intravenous (IV) iron sucrose at 32 6/7 weeks of gestation. On admission to the hospital, creatine kinase was 2,437 units/L, sodium was 132 mEq/L, and potassium was 2.1 mEq/L. Intravenous fluids and electrolyte repletion were administered, with improvement of symptoms within 48 hours. Creatinine kinase normalized 1 week after hospital discharge. Rhabdomyolysis can be associated with IV iron infusion during pregnancy.
doi_str_mv 10.1097/AOG.0000000000005157
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2810919554</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2810919554</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3521-170ac87c31ea2984a97382bba91999b890df6bf72e72b3214f139befe7d91f0d3</originalsourceid><addsrcrecordid>eNpdkMtOwzAQRS0EoqXwBwhlySbFYye1vawKlEqVinhI7CI7sdtAHsVOqPL3uLQ8xGxGmrlz5-ogdA54CFiwq_FiOsR_KoaYHaA-cEZDQunLIepjTETIeBT10Ilzr14EI0GPUY8yiCDmcR9NH1ZSZXXZ1UXncheMTaNtMKsaKz90VbcumNm6Ch7b1NZO-4VpXe4H163Nq2Vwb_WyklXanaIjIwunz_Z9gJ5vb54md-F8MZ1NxvMwpTGBEBiWKWcpBS2J4JEUjHKilBQghFBc4MyMlGFEM6IogcgAFUobzTIBBmd0gC53vmtbv7faNUmZu1QXhay0T5sQ7uGAiOPIS6OddBvdWW2Stc1LabsEcLJFmHiEyX-E_uxi_6FVpc5-jr6Z_fpu6sLDcm9Fu9E2WWlZNKsvvxGJcSjE3jXEmDGgnznne4o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2810919554</pqid></control><display><type>article</type><title>Rhabdomyolysis After Intravenous Iron Sucrose Infusion During Pregnancy</title><source>Journals@Ovid Complete</source><creator>Ge, Christina ; Reyes, Jessica ; Queenan, Ruth Anne ; Gherman, Robert B.</creator><creatorcontrib>Ge, Christina ; Reyes, Jessica ; Queenan, Ruth Anne ; Gherman, Robert B.</creatorcontrib><description>Iron infusions have become increasingly common in the treatment of iron-deficiency anemia during pregnancy. Although iron infusions are generally well tolerated, adverse reactions have been reported. A pregnant patient was diagnosed with rhabdomyolysis after receiving a second dose of intravenous (IV) iron sucrose at 32 6/7 weeks of gestation. On admission to the hospital, creatine kinase was 2,437 units/L, sodium was 132 mEq/L, and potassium was 2.1 mEq/L. Intravenous fluids and electrolyte repletion were administered, with improvement of symptoms within 48 hours. Creatinine kinase normalized 1 week after hospital discharge. Rhabdomyolysis can be associated with IV iron infusion during pregnancy.</description><identifier>ISSN: 0029-7844</identifier><identifier>EISSN: 1873-233X</identifier><identifier>DOI: 10.1097/AOG.0000000000005157</identifier><identifier>PMID: 37141585</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><ispartof>Obstetrics and gynecology (New York. 1953), 2023-06, Vol.141 (6), p.1049-1051</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><rights>Copyright © 2023 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3521-170ac87c31ea2984a97382bba91999b890df6bf72e72b3214f139befe7d91f0d3</citedby><cites>FETCH-LOGICAL-c3521-170ac87c31ea2984a97382bba91999b890df6bf72e72b3214f139befe7d91f0d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37141585$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ge, Christina</creatorcontrib><creatorcontrib>Reyes, Jessica</creatorcontrib><creatorcontrib>Queenan, Ruth Anne</creatorcontrib><creatorcontrib>Gherman, Robert B.</creatorcontrib><title>Rhabdomyolysis After Intravenous Iron Sucrose Infusion During Pregnancy</title><title>Obstetrics and gynecology (New York. 1953)</title><addtitle>Obstet Gynecol</addtitle><description>Iron infusions have become increasingly common in the treatment of iron-deficiency anemia during pregnancy. Although iron infusions are generally well tolerated, adverse reactions have been reported. A pregnant patient was diagnosed with rhabdomyolysis after receiving a second dose of intravenous (IV) iron sucrose at 32 6/7 weeks of gestation. On admission to the hospital, creatine kinase was 2,437 units/L, sodium was 132 mEq/L, and potassium was 2.1 mEq/L. Intravenous fluids and electrolyte repletion were administered, with improvement of symptoms within 48 hours. Creatinine kinase normalized 1 week after hospital discharge. Rhabdomyolysis can be associated with IV iron infusion during pregnancy.</description><issn>0029-7844</issn><issn>1873-233X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpdkMtOwzAQRS0EoqXwBwhlySbFYye1vawKlEqVinhI7CI7sdtAHsVOqPL3uLQ8xGxGmrlz5-ogdA54CFiwq_FiOsR_KoaYHaA-cEZDQunLIepjTETIeBT10Ilzr14EI0GPUY8yiCDmcR9NH1ZSZXXZ1UXncheMTaNtMKsaKz90VbcumNm6Ch7b1NZO-4VpXe4H163Nq2Vwb_WyklXanaIjIwunz_Z9gJ5vb54md-F8MZ1NxvMwpTGBEBiWKWcpBS2J4JEUjHKilBQghFBc4MyMlGFEM6IogcgAFUobzTIBBmd0gC53vmtbv7faNUmZu1QXhay0T5sQ7uGAiOPIS6OddBvdWW2Stc1LabsEcLJFmHiEyX-E_uxi_6FVpc5-jr6Z_fpu6sLDcm9Fu9E2WWlZNKsvvxGJcSjE3jXEmDGgnznne4o</recordid><startdate>20230601</startdate><enddate>20230601</enddate><creator>Ge, Christina</creator><creator>Reyes, Jessica</creator><creator>Queenan, Ruth Anne</creator><creator>Gherman, Robert B.</creator><general>Lippincott Williams &amp; Wilkins</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20230601</creationdate><title>Rhabdomyolysis After Intravenous Iron Sucrose Infusion During Pregnancy</title><author>Ge, Christina ; Reyes, Jessica ; Queenan, Ruth Anne ; Gherman, Robert B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3521-170ac87c31ea2984a97382bba91999b890df6bf72e72b3214f139befe7d91f0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ge, Christina</creatorcontrib><creatorcontrib>Reyes, Jessica</creatorcontrib><creatorcontrib>Queenan, Ruth Anne</creatorcontrib><creatorcontrib>Gherman, Robert B.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ge, Christina</au><au>Reyes, Jessica</au><au>Queenan, Ruth Anne</au><au>Gherman, Robert B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rhabdomyolysis After Intravenous Iron Sucrose Infusion During Pregnancy</atitle><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle><addtitle>Obstet Gynecol</addtitle><date>2023-06-01</date><risdate>2023</risdate><volume>141</volume><issue>6</issue><spage>1049</spage><epage>1051</epage><pages>1049-1051</pages><issn>0029-7844</issn><eissn>1873-233X</eissn><abstract>Iron infusions have become increasingly common in the treatment of iron-deficiency anemia during pregnancy. Although iron infusions are generally well tolerated, adverse reactions have been reported. A pregnant patient was diagnosed with rhabdomyolysis after receiving a second dose of intravenous (IV) iron sucrose at 32 6/7 weeks of gestation. On admission to the hospital, creatine kinase was 2,437 units/L, sodium was 132 mEq/L, and potassium was 2.1 mEq/L. Intravenous fluids and electrolyte repletion were administered, with improvement of symptoms within 48 hours. Creatinine kinase normalized 1 week after hospital discharge. Rhabdomyolysis can be associated with IV iron infusion during pregnancy.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>37141585</pmid><doi>10.1097/AOG.0000000000005157</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0029-7844
ispartof Obstetrics and gynecology (New York. 1953), 2023-06, Vol.141 (6), p.1049-1051
issn 0029-7844
1873-233X
language eng
recordid cdi_proquest_miscellaneous_2810919554
source Journals@Ovid Complete
title Rhabdomyolysis After Intravenous Iron Sucrose Infusion During Pregnancy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T17%3A24%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rhabdomyolysis%20After%20Intravenous%20Iron%20Sucrose%20Infusion%20During%20Pregnancy&rft.jtitle=Obstetrics%20and%20gynecology%20(New%20York.%201953)&rft.au=Ge,%20Christina&rft.date=2023-06-01&rft.volume=141&rft.issue=6&rft.spage=1049&rft.epage=1051&rft.pages=1049-1051&rft.issn=0029-7844&rft.eissn=1873-233X&rft_id=info:doi/10.1097/AOG.0000000000005157&rft_dat=%3Cproquest_cross%3E2810919554%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2810919554&rft_id=info:pmid/37141585&rfr_iscdi=true